drugset / Trial / NCT01710462

Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux Disease

NCT01710462 ↗

Phase 3 Withdrawn Eurofarma Laboratorios S.A.
RandomizedParallel-groupSingle-blindTreatment

Summary

This superiority phase III study to compare the combination of Pantoprazole and Domperidone with Pantoprazole isolated to the treatment of gastroesophageal reflux disease. The hypothesis is that combination of the two medication at the unique capsule is better to the patients because decrease the quantity of times the patients need to take medicines during the day.

Timeline

Start
2013-08
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped (Business): “Change of company's strategy”

Drugs

EvaluationDrugModalityDoseRoute
Subject Domperidone Unknown 20 mg —
Subject Pantoprazole Other / unclassified 20 mg —